Literature DB >> 32938708

Postpartum long-acting contraception uptake and service delivery outcomes after a multilevel intervention in Kigali, Rwanda.

Julie Espey1, Rosine Ingabire1,2, Julien Nyombayire1,2, Alexandra Hoagland1,2, Vanessa Da Costa1, Amelia Mazzei1,2, Lisa B Haddad3, Rachel Parker1, Jeannine Mukamuyango1,2, Victoria Umutoni1, Susan Allen1, Etienne Karita1,2, Amanda Tichacek1, Kristin M Wall4,5.   

Abstract

INTRODUCTION: Postpartum family planning (PPFP) is critical to reduce maternal-child mortality, abortion and unintended pregnancy. As in most countries, the majority of PP women in Rwanda have an unmet need for PPFP. In particular, increasing use of the highly effective PP long-acting reversible contraceptive (LARC) methods (the intrauterine device (IUD) and implant) is a national priority. We developed a multilevel intervention to increase supply and demand for PPFP services in Kigali, Rwanda.
METHODS: We implemented our intervention (which included PPFP promotional counselling for clients, training for providers, and Ministry of Health stakeholder involvement) in six government health facilities from August 2017 to October 2018. While increasing knowledge and uptake of the IUD was a primary objective, all contraceptive method options were discussed and made available. Here, we report a secondary analysis of PP implant uptake and present already published data on PPIUD uptake for reference.
RESULTS: Over a 15-month implementation period, 12 068 women received PPFP educational counselling and delivered at a study facility. Of these women, 1252 chose a PP implant (10.4% uptake) and 3372 chose a PPIUD (27.9% uptake). On average providers at our intervention facilities inserted 83.5 PP implants/month and 224.8 PPIUDs/month. Prior to our intervention, 30 PP implants/month and 8 PPIUDs/month were inserted at our selected facilities. Providers reported high ease of LARC insertion, and clients reported minimal insertion anxiety and pain.
CONCLUSIONS: PP implant and PPIUD uptake significantly increased after implementation of our multilevel intervention. PPFP methods were well received by clients and providers. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  contraceptive devices; counseling; family planning services; female; reproductive health services

Mesh:

Year:  2020        PMID: 32938708      PMCID: PMC8861892          DOI: 10.1136/bmjsrh-2020-200741

Source DB:  PubMed          Journal:  BMJ Sex Reprod Health        ISSN: 2515-1991


  21 in total

1.  Postpartum contraception utilization among low-income women seeking immunization for infants in Mumbai, India.

Authors:  Sheila K Mody; Saritha Nair; Anindita Dasgupta; Anita Raj; Balaiah Donta; Niranjan Saggurti; D D Naik; Jay G Silverman
Journal:  Contraception       Date:  2014-01-10       Impact factor: 3.375

2.  Development and Uptake of Long-Acting Reversible Contraception Services in Rwanda, 2009-2016.

Authors:  Rosine Ingabire; Jeannine Mukamuyango; Julien Nyombayire; Sarah Rae Easter; Rachel Parker; Amelia Mazzei; Robertine Sinabamenye; Amanda Tichacek; Susan Allen; Etienne Karita; Kristin M Wall
Journal:  J Womens Health (Larchmt)       Date:  2019-07-05       Impact factor: 2.681

3.  Integrated Family Planning and Routine Child Immunization Services in Benin: A Process Evaluation.

Authors:  Blake Erhardt-Ohren; Heidi Schroffel; Roger Rochat
Journal:  Matern Child Health J       Date:  2020-06

4.  Integrating family planning messages into immunization services: a cluster-randomized trial in Ghana and Zambia.

Authors:  Gwyneth Vance; Barbara Janowitz; Mario Chen; Brooke Boyer; Prisca Kasonde; Gloria Asare; Beatrice Kafulubiti; John Stanback
Journal:  Health Policy Plan       Date:  2013-04-09       Impact factor: 3.344

5.  Meeting Postpartum Women's Family Planning Needs Through Integrated Family Planning and Immunization Services: Results of a Cluster-Randomized Controlled Trial in Rwanda.

Authors:  Lisa S Dulli; Marga Eichleay; Kate Rademacher; Steve Sortijas; Théophile Nsengiyumva
Journal:  Glob Health Sci Pract       Date:  2016-03-25

6.  Intentions on contraception use and its associated factors among postpartum women in Aksum town, Tigray region, northern Ethiopia: a community-based cross- sectional study.

Authors:  Teklehaymanot Huluf Abraha; Hailay Siyum Belay; Getachew Mebrahtu Welay
Journal:  Reprod Health       Date:  2018-11-09       Impact factor: 3.223

7.  Evaluation of a multi-level intervention to improve postpartum intrauterine device services in Rwanda.

Authors:  Rosine Ingabire; Julien Nyombayire; Alexandra Hoagland; Vanessa Da Costa; Amelia Mazzei; Lisa Haddad; Rachel Parker; Robertine Sinabamenye; Jeannine Mukamuyango; Julie Smith; Victoria Umutoni; Ellen Mork; Susan Allen; Etienne Karita; Kristin M Wall
Journal:  Gates Open Res       Date:  2018-10-10

8.  Community health worker promotions increase uptake of long-acting reversible contraception in Rwanda.

Authors:  Amelia Mazzei; Rosine Ingabire; Jeannine Mukamuyango; Julien Nyombayire; Robertine Sinabamenye; Roger Bayingana; Rachel Parker; Amanda Tichacek; Sarah Rae Easter; Etienne Karita; Susan Allen; Kristin M Wall
Journal:  Reprod Health       Date:  2019-06-04       Impact factor: 3.223

9.  Associated Factors of Postpartum Modern Contraceptive Use in Burie District, Amhara Region, Ethiopia.

Authors:  Wassachew Ashebir; Tilahun Tadesse
Journal:  J Pregnancy       Date:  2020-03-21

10.  Rwandan stakeholder perspectives of integrated family planning and HIV services.

Authors:  Kristin M Wall; Roger Bayingana; Rosine Ingabire; Lauren Ahlschlager; Amanda Tichacek; Susan Allen; Etienne Karita
Journal:  Int J Health Plann Manage       Date:  2018-07-26
View more
  1 in total

1.  Implementation and evaluation of a large-scale postpartum family planning program in Rwanda: study protocol for a clinic-randomized controlled trial.

Authors:  Kristin M Wall; Rosine Ingabire; Amelia Mazzei; Claudine Umuhoza; Rachel Parker; Amanda Tichacek; Azhar Nizam; Jessica M Sales; Lisa B Haddad; Phaedra Corso; Susan Allen; Julien Nyombayire; Etienne Karita
Journal:  Trials       Date:  2022-04-22       Impact factor: 2.728

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.